HOME >> MEDICINE >> NEWS
Common cold may be just a fingertip away due to environmental contamination

PARSIPPANY, N.J., Sept. 29 -- A common cold can be just a fingertip away thanks to the high rate of viral contamination of environmental surfaces that a cold sufferer can leave behind, according to a study in hotel rooms by investigators from the University of Virginia (UVa) and Reckitt-Benckiser (LON: RB), the world's number one household cleaning company (excluding laundry). The study was presented today in an oral session at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), in San Francisco, California.

During daily activities, adults infected with the cold virus easily transferred the virus to 35 percent of the surfaces touched, according to the study. Moreover, it was found that the virus was effortlessly and significantly transferred to an uninfected person by fingertips touching the contaminated surfaces, even 18 hours after initial contamination, according to Owen Hendley, M.D., lead study investigator and Professor of Pediatrics in the Division of Pediatric Infectious Diseases at the UVa Health System.

After an overnight stay, adults infected with rhinovirus left behind virus on about a third of the objects and surfaces they touched in their daily activities. For example, the most frequently contaminated objects in 15 individually occupied hotel rooms were door handles (seven out of 14 rooms) and pens (six out of 14 rooms), followed by light switches, TV remote controls and faucets (each six out of 15 rooms), and telephones (five out of 15 rooms). Remarkably, the investigators noted that only one out of 10 rooms had a contaminated toilet handle.

Overall, rhinovirus contamination of the sampled surfaces (10 each in of 15 rooms) ranged from 80 percent contaminated test surfaces in three rooms to 30-50 percent in 7 rooms, to 10 percent in 3 rooms and none in two rooms. The average contamination rate was 35 percent.

Rates of acquiring rhinovirus from a contaminated surface during daily l
'"/>

Contact: Erin Osher
212-601-8352
Porter Novelli
29-Sep-2006


Page: 1 2 3 4

Related medicine news :

1. Commonly used drug offers promise for premature babies
2. Commonly used pain medications do not prevent Alzheimers disease
3. Common anesthetic may induce cell death, generation of Alzheimers-associated protein
4. Common blood pressure drug treats muscular dystrophy in mice
5. Common PTSD drug is no more effective than placebo
6. Commonwealth Fund commission says the US health care system needs thorough transformation
7. Commonly recommended sedative does not improve infant sleep
8. Common asthma inhaler causing deaths, researchers assert
9. Common painkillers associated with increased risk of first hospital admission for heart failure
10. Commonly used blood pressure medication prevents aortic aneurysm in mice with Marfan syndrome
11. Common osteoporosis treatment may help men with prostate cancer suffering from bone loss

Post Your Comments:
(Date:5/22/2013)... 22, 2013 GS1 has honored Tim ... Company, and Danny Wegman, CEO, Wegmans Food Markets, ... General Assembly and Global Leadership Summit, held May 20-23 ... were recognized for their outstanding contributions to the advancement ... used supply chain standards globally. , “The leadership, ...
(Date:5/22/2013)... and teens exposed to radiation during CT scans are ... a large, long-term study. The risks, however, are ... who each had one CT scan, only about six ... years, according to researchers from Australia and Europe. ... to patients when making decisions about CT (computed tomography) ...
(Date:5/22/2013)... This news release is available in German . ... Forschungsgemeinschaft (DFG, German Research Foundation) is establishing 11 new ... in Germany. This decision was made by the relevant ... euros has been awarded to the new programmes for ... In addition to the 11 new Research Training Groups, ...
(Date:5/22/2013)... to finish the last ounce in their bottle might be ... burn off, a bad habit remains. , Brigham Young University ... obesity at 24 months of age strongly traces back to ... it puts you on a trajectory where you are likely ... an adult," said Forste. "That,s a big concern." , The ...
(Date:5/22/2013)... May 22, 2013 The new 13-valent pneumococcal ... the previous version used prior to 2010, the 7-valent ... study published today in Vaccine . , The ... beginning in 2010 after a series of trials. These ... range of pneumococcal types than the previously used PCV7, ...
Breaking Medicine News(10 mins):Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 2Health News:Tim Smucker and Danny Wegman Honored With GS1 Lifetime Achievement Awards 3Health News:Children Who Have CT Scans May Face Higher Cancer Risk 2Health News:DFG establishes 11 new research training groups 2Health News:DFG establishes 11 new research training groups 3Health News:DFG establishes 11 new research training groups 4Health News:DFG establishes 11 new research training groups 5Health News:Overeating learned in infancy, study suggests 2Health News:Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine 2
(Date:5/22/2013)... , May 22, 2013  Avanir Pharmaceuticals, Inc. (NASDAQ: ... present an overview of the company at the following conferences. ... , Presentation date: Wednesday May 29, 2013 , ... 2013 Global Healthcare Conference , Presentation date: Wednesday June ... A live webcast and 30-day ...
(Date:5/22/2013)... Mass. , May 22, 2013  Flagship ... firm focused on healthcare and sustainability, today announced ... as a Senior Partner. In this role, ... to portfolio companies. In addition to ... Mr. Bancel also serves as President and Chief ...
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
Breaking Medicine Technology:Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 2Life Science Industry Veteran Stephane Bancel Joins Flagship Ventures 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4
Cached News: